APA (7th ed.) Citation

A, G., M, L., A, Y., A, N., M, B., G, M., . . . B, O. (2023). Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria. Malaria journal, 22(1), 2. https://doi.org/10.1186/s12936-022-04420-2

Chicago Style (17th ed.) Citation

A, Gansane, et al. "Randomized, Open-label, Phase 2a Study to Evaluate the Contribution of Artefenomel to the Clinical and Parasiticidal Activity of Artefenomel Plus Ferroquine in African Patients with Uncomplicated Plasmodium Falciparum Malaria." Malaria Journal 22, no. 1 (2023): 2. https://doi.org/10.1186/s12936-022-04420-2.

MLA (9th ed.) Citation

A, Gansane, et al. "Randomized, Open-label, Phase 2a Study to Evaluate the Contribution of Artefenomel to the Clinical and Parasiticidal Activity of Artefenomel Plus Ferroquine in African Patients with Uncomplicated Plasmodium Falciparum Malaria." Malaria Journal, vol. 22, no. 1, 2023, p. 2, https://doi.org/10.1186/s12936-022-04420-2.